Nanotechnology against bacterial resistance
Research investigates the use of nanoparticles to accurately deliver drugs to pathogens
Antibiotic resistant bacteria are one of the most alarming public health problems, causing approximately 700,000 fatalities each year. The emergence of new resistant bacteria and the lack of effective drugs are some of the challenges in this complex medical landscape. If nothing is done, this number is estimated to rise to around 10 million deaths by 2050.
The administration of multiple cycles of antibiotics stimulates the emergence of resistant bacteria, and multidrug-resistant pathogens force patients into prolonged hospital stays, also increasing the costs associated with treatment.